Evidence map›Paper›PMID 35943005›Full record

ArticleArchives of Iranian medicine2022

Validation of Persian Version of Mindful Attention Awareness Scale (MAAS) in Iranian Women with Breast Cancer.

Roghieh Nooripour, Nikzad Ghanbari, Peyman Hassani-Abharian, Laurel E Radwin, Simin Hosseinian, Saba Hasanvandi

Abstract read
In one paragraph

Article in Archives of Iranian medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Roghieh NooripourDepartment of Counseling, Faculty of Education and Psychology, Alzahra University, Tehran, Iran.ORCID 0000-0002-5677-0894
Nikzad GhanbariFaculty of Education and Psychology, Shahid Beheshti University (SBU), Tehran, Iran.
Peyman Hassani-AbharianInstitute for Cognitive Science Studies (IRICSS), Department of Cognitive Rehabilitation, Brain and Cognition Clinic, Tehran, Iran.ORCID 0000-0003-4683-066X
Laurel E RadwinCenter for Health Care Organizational and Implementation Research (CHOIR), VA Boston Healthcare System, Boston, MA, USA.
Simin HosseinianDepartment of Counseling, Faculty of Education and Psychology, Alzahra University, Tehran, Iran.
Saba HasanvandiDepartment of Psychology, Faculty of Humanistic Sciences, Khorramabad Branch, Islamic Azad University, Khorram Abad, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBreast cancer is now the most significant health issue in women, threatening diverse aspects of human health, including mental health and cognitive function. This research aimed to validate the Persian version of Mindful Attention Awareness Scale (MAAS) in Iranian women with breast cancer.

methodsWe gathered data on 229 women with breast cancer in Tehran through convenience sampling. They completed a demographic questionnaire, the Persian version of MAAS, the General Self-Efficacy Scale, and DASS-21. SPSS-22 analyzed the Pearson correlation between the Persian version of MAAS, general self-efficacy, and DASS-21. Also, LISREL 8.8 was used to analyze the internal structure of the MAAS.

resultsFindings from the confirmatory factor analysis (CFA) showed that the model with one factor fits well with the data (

conclusionThe Persian version of MAAS seems to be a valid scale for evaluating the extent of mindfulness of Iranian women with breast cancer.

Indexed as

AwarenessBreast NeoplasmsAttentionFemaleHumansIranPsychometricsReproducibility of ResultsSurveys and QuestionnairesBreast cancerIranian womenMindful Attention Awareness Scale (MAAS)Mindfulness

Identifiers

PMID35943005
PMCPMC11904298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.